Talene A. Yacoubian, Ph.D. - Publications

Duke University, Durham, NC 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Apetauerova D, Scala SA, Hamill RW, Simon DK, Pathak S, Ruthazer R, Standaert DG, Yacoubian TA. CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial. Neurology® Neuroimmunology & Neuroinflammation. 3: e266. PMID 27583276 DOI: 10.1212/NXI.0000000000000266  0.88
2015 Lavalley NJ, Slone SR, Ding H, West AB, Yacoubian TA. 14-3-3 proteins regulate mutant LRRK2 kinase activity and neurite shortening. Human Molecular Genetics. PMID 26546614 DOI: 10.1093/hmg/ddv453  0.88
2014 Yacoubian TA, Standaert DG. Reaping what you sow: Cross-seeding between aggregation-prone proteins in neurodegeneration. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 306. PMID 24395732 DOI: 10.1002/mds.25766  0.88
2013 Fraser KB, Moehle MS, Daher JP, Webber PJ, Williams JY, Stewart CA, Yacoubian TA, Cowell RM, Dokland T, Ye T, Chen D, Siegal GP, Galemmo RA, Tsika E, Moore DJ, et al. LRRK2 secretion in exosomes is regulated by 14-3-3. Human Molecular Genetics. 22: 4988-5000. PMID 23886663 DOI: 10.1093/hmg/ddt346  0.88
2013 Steidinger TU, Slone SR, Ding H, Standaert DG, Yacoubian TA. Angiogenin in Parkinson disease models: role of Akt phosphorylation and evaluation of AAV-mediated angiogenin expression in MPTP treated mice. Plos One. 8: e56092. PMID 23409128 DOI: 10.1371/journal.pone.0056092  0.88
2012 Harrington AJ, Yacoubian TA, Slone SR, Caldwell KA, Caldwell GA. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 2142-53. PMID 22323726 DOI: 10.1523/JNEUROSCI.2606-11.2012  0.88
2011 Lee YJ, Wang S, Slone SR, Yacoubian TA, Witt SN. Defects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease. Plos One. 6: e15946. PMID 21264320 DOI: 10.1371/journal.pone.0015946  0.88
2011 Steidinger TU, Standaert DG, Yacoubian TA. A neuroprotective role for angiogenin in models of Parkinson's disease. Journal of Neurochemistry. 116: 334-41. PMID 21091473 DOI: 10.1111/j.1471-4159.2010.07112.x  0.88
2010 Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA, Caldwell GA, Standaert DG. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death & Disease. 1: e2. PMID 21152247 DOI: 10.1038/cddis.2009.4  0.88
2010 Standaert DG, Yacoubian TA. Target validation: the Parkinson disease perspective. Disease Models & Mechanisms. 3: 259-62. PMID 20427553 DOI: 10.1242/dmm.004192  0.88
2009 Yacoubian TA, Howard G, Kissela B, Sands CD, Standaert DG. Racial differences in Parkinson's disease medication use in the reasons for geographic and racial differences in stroke cohort: a cross-sectional study. Neuroepidemiology. 33: 329-34. PMID 19887838 DOI: 10.1159/000254568  0.88
2009 Yacoubian TA, Standaert DG. Targets for neuroprotection in Parkinson's disease. Biochimica Et Biophysica Acta. 1792: 676-87. PMID 18930814 DOI: 10.1016/j.bbadis.2008.09.009  0.88
2008 Qiao L, Hamamichi S, Caldwell KA, Caldwell GA, Yacoubian TA, Wilson S, Xie ZL, Speake LD, Parks R, Crabtree D, Liang Q, Crimmins S, Schneider L, Uchiyama Y, Iwatsubo T, et al. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Molecular Brain. 1: 17. PMID 19021916 DOI: 10.1186/1756-6606-1-17  0.88
2008 Yacoubian TA, Cantuti-Castelvetri I, Bouzou B, Asteris G, McLean PJ, Hyman BT, Standaert DG. Transcriptional dysregulation in a transgenic model of Parkinson disease. Neurobiology of Disease. 29: 515-28. PMID 18191405 DOI: 10.1016/j.nbd.2007.11.008  0.88
2000 Yacoubian TA, Lo DC. Truncated and full-length TrkB receptors regulate distinct modes of dendritic growth. Nature Neuroscience. 3: 342-9. PMID 10725923 DOI: 10.1038/73911  0.88
Show low-probability matches.